2023. [Cost-Effectiveness Analysis of Maribavir in Patients with Post-Transplant Cytomegalovirus Infection or Disease that are Refractory or Resistant to Conventional Therapy]. Farmeconomia. Health Economics and Therapeutic Pathways. 24, 1 (Dec. 2023). DOI:https://doi.org/10.7175/fe.v24i1.1548.